Virtue Diagnostics develops in vitro diagnostic systems utilizing clinical mass spectrometry, chemiluminescence, and multiplex pathology technologies to provide precise solutions for infectious diseases, cancer, and chronic conditions. Their platforms enable early screening, accurate diagnosis, and effective treatment monitoring, addressing the need for affordable and reliable diagnostics in emerging markets.
Funding
$100M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MFounders
Product
Problem
Clinical diagnostic processes often require multiple technology platforms to cover the full spectrum of disease stages, from early screening to treatment monitoring. Existing diagnostic solutions may lack the sensitivity, specificity, or automation needed for efficient and reliable results, particularly in emerging markets with limited resources.
Solution
Virtue Diagnostics develops and manufactures in vitro diagnostic (IVD) systems that leverage clinical mass spectrometry, chemiluminescence, multiplex pathology, and other advanced technologies. Their integrated platforms provide solutions for infectious diseases, cancer, and chronic conditions, enabling early screening, accurate diagnosis, and effective treatment monitoring. By combining diverse technology platforms with automated workstations, Virtue Diagnostics aims to streamline laboratory workflows, reduce errors, and improve the overall quality of diagnostic testing. The company's focus on collaborative R&D and industrialization allows them to adapt advanced diagnostic technologies to meet the specific needs of both developed and emerging markets.
Target Audience
Virtue Diagnostics primarily serves clinical laboratories, hospitals, and healthcare providers seeking comprehensive and reliable diagnostic solutions for infectious diseases, cancer, and chronic conditions.
Features
- Clinical mass spectrometry platform for precise analysis of metabolites, vitamins, steroids, and hormones
- Chemiluminescence immunoassay technology offering enzyme-linked, direct, and electrochemiluminescence options
- Fully automated biochemical analyzers for measuring various biochemical indicators in blood and body fluids
- Hematology platforms for rapid and accurate classification and counting of blood cells
- Multiplex pathology solutions for identifying molecular markers in tissue and cells
- Automated workstations for chemiluminescence, clinical mass spectrometry, and molecular biology technologies
- Integrated systems including staining machines, image analysis, and software with registered reagents as IVD kits